]>
IRCT20200326046868N1 IRCT 2020-05-09 Abadan University of Medical Sciences effect of propolis in COVID-19 The effect of propolis supplementation on clinical manifestations and inflammatory biomarkers in patients with COVID-19 2020-05-21 anticipated 88 Complete https://irct.ir/trial/47934 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this triple blind study, patient, physician (treatment team) and the data analyzer did not know the type of data and supplements.Allocate patients to two intervention and control groups so that the list of subjects studied will be randomly generated by a computer.The intervention and control group will be placed inside the numbered envelopes and will be sealed, Blinding description: In this study patients, Physician and researcher don't know which group of patients will use the medicine placebo. 3 Covid-19. Intervention 1: Intervention group: The propolis supplement is taken as a 500 mg capsule twice a day for 1 month. Intervention 2: Control group: The placebo is taken as a capsule twice a day for 1 month. Yes - There is a plan to make this available What will be shared: All potential data can be shared after people have not been identified When: Since 2021 To whom: Researchers working in academic and scientific institutions Conditions: No other conditions are considered Where to obtain: Email of Responsible person How to obtain: 1 week after receiving email Comments:
public Reza Malihi
Abadan School of Medical Sciences,Beginning of the 30 meters Ave, Zolfaghari street, Abadan city.
Ahvaz Iran (Islamic Republic of) 631911154 +98 61 3555 0592 r.malihi@abadanums.ac.ir Abadan University of Medical Sciences scientific Reza Malihi
Abadan School of Medical Sciences,Beginning of the 30 meters Ave, Zolfaghari street, Abadan city.
ŮŽAbadan Iran (Islamic Republic of) 631911154 +98 61 5338 4004 r.malihi@abadanums.ac.ir Abadan University of Medical Sciences Iran (Islamic Republic of) Patients aged 18 to 65 years Laboratory confirmation of Covid-19 (2019-nCoV Real-Time RT-PCR) 18 years 65 years Both Pregnancy and lactation, a history of allergies to honey and bee products, uncontrolled underlying disease including neuropsychiatric problems, diabetes, thyroid disorders, heart disease, chronic liver or kidney failure, and autoimmune diseases. U07.1 Other coronavirus as the cause of diseases classified elsewhere Treatment - Drugs Placebo Intervention group: The propolis supplement is taken as a 500 mg capsule twice a day for 1 month Control group: The placebo is taken as a capsule twice a day for 1 month Cough. Timepoint: First and 30 days after the intervention. Method of measurement: Clinical examination. Oxygen saturation. Timepoint: First and 30 days after the intervention. Method of measurement: Clinical examination. Respiratory rate. Timepoint: First and 30 days after the intervention. Method of measurement: Clinical examination. Body temperature. Timepoint: First and 30 days after the intervention. Method of measurement: Clinical examination. LI-6. Timepoint: First and 30 days after the intervention. Method of measurement: ELISA. TNF alpha. Timepoint: First and 30 days after the intervention. Method of measurement: ELISA. Crp-hs. Timepoint: First and 30 days after the intervention. Method of measurement: ELISA. CBC. Timepoint: First and 30 days after the intervention. Method of measurement: Cell counter. Abadan University of Medical Sciences Approved 2020-04-26 Ethics Committee of Abadan School of Medical Sciences Abadan School of Medical Sciences,Beginning of the 30 meters Ave, Zolfaghari street, Abadan city. Ahvaz Khouzestan Iran (Islamic Republic of)